bioAffinity Technologies Announces Award of European Union Patent
May 03, 2017 14:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, Texas, May 03, 2017 (GLOBE NEWSWIRE) -- bioAffinity Technologies announced that the European Patent Office (EPO) has issued a patent that protects the Company’s proprietary CyPath®...
TESARO Announces Expanded Development Program for Niraparib Focused on the Treatment of Front-Line Metastatic Ovarian and Lung Cancers and Metastatic Breast Cancer
March 27, 2017 15:45 ET
|
TESARO, Inc.
Expanded niraparib ovarian cancer program intended to potentially transform the treatment of front-line ovarian cancerNew breast cancer clinical program for niraparib to address greatest area of unmet...
GenomOncology and med fusion announce the addition of PD-L1 Testing and Interpretation to the LungSEQ® and 50SEQ® Plus FISH Tests
March 07, 2017 09:00 ET
|
Genomoncology
CLEVELAND, March 07, 2017 (GLOBE NEWSWIRE) -- med fusion, a Texas Oncology and The US Oncology Network preferred laboratory, and GenomOncology announce the expansion of med fusion’s LungSEQ® and...
Allsup Cites New Study Tying Depression To Poorer Chemotherapy Outcomes In Lung Cancer Patients
January 23, 2017 09:30 ET
|
Allsup
BELLEVILLE, IL--(Marketwired - January 23, 2017) - A recent study of patients with lung cancer highlights the significance depression may have on treatment outcomes and the ability to work, according...
Zusammenfassung der Forschungspräsentationen bei der 17. Welt-Lungenkrebs-Konferenz der Internationalen Vereinigung für das Studium von Lungenkrebs (International Association for the Study of Lung Cancer, IASLC) am Dienstag, dem 6. Dezember 2016
December 07, 2016 04:58 ET
|
IASLC
WIEN, ÖSTERREICH--(Marketwired - 7. Dezember 2016) - Die heutige Presseinformation zur 17. Welt-Lungenkrebs-Konferenz (World Conference on Lung Cancer, WCLC) der IASLC setzte den Akzent auf aktive...
Resumen de las presentaciones de investigación de la 17ª Conferencia Mundial sobre el Cáncer de Pulmón de la IASLC, martes 6 de diciembre de 2016
December 06, 2016 22:07 ET
|
IASLC
VIENA, AUSTRIA--(Marketwired - 6 de diciembre de 2016) - La rueda de prensa de hoy en la 17ª Conferencia Mundial sobre Cáncer de Pulmón (WCLC) de la IASLC se centró en la prevención activa. Los...
Résumé des présentations d'études de la 17e Conférence mondiale sur le cancer du poumon de l'IASLC (mardi 6 décembre 2016)
December 06, 2016 20:06 ET
|
IASLC
VIENNE, AUTRICHE--(Marketwired - 6 décembre 2016) - Le point-presse d'aujourd'hui à l'occasion de la 17e Conférence mondiale sur le cancer du poumon (WCLC) de l'IASLC s'est concentré sur la...
Resumo das Apresentações das Pesquisas na IASLC 17a Conferência Mundial sobre Câncer de Pulmão de terça-feira, dia 6 de dezembro de 2016
December 06, 2016 18:33 ET
|
IASLC
VIENNA, AUSTRIA--(Marketwired - 6 de dezembro de 2016) - A coletiva com a mídia de hoje na IASLC 17a Conferência Mundial sobre o Câncer de Pulmão (World Conference on Lung Cancer - WCLC)...
Summary of Research Presentations From the IASLC 17th World Conference on Lung Cancer Tuesday, December 6, 2016
December 06, 2016 09:31 ET
|
IASLC
VIENNA, AUSTRIA--(Marketwired - December 06, 2016) - Today's press briefing at the IASLC 17th World Conference on Lung Cancer (WCLC) focused on active prevention, with researchers sharing results of...
Fürsprecher der öffentlichen Gesundheit aus aller Welt sagen dem Tabak an weiteren Fronten den Kampf an
December 06, 2016 07:57 ET
|
IASLC
WIEN, ÖSTERREICH--(Marketwired - 6. Dezember 2016) - Die Bemühungen, Tabak als Gefahr für die öffentliche Gesundheit zu regulieren, haben sich enorm ausgeweitet. Mediziner und Fürsprecher der...